ONC213
Live / Applied — Third extension granted (statement of use) (as of 02 Apr 2026)
What this means for you
Not registered yet, but its 08 Sept 2023 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98171928
- Mark type
- Stylized text
- Filed
- 08 Sept 2023
- Published for opposition
- 13 Aug 2024
- Attorney of record
- Brendan J. Hughes
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceuticals and pharmaceutical preparations for use in the treatment of oncological and neurological diseases and disorders
Owner
- Chimerix, Inc., Durham, NC, US
- Chimerix, Inc., Durham, NC, US
Prosecution history
- 03 Apr 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 02 Apr 2026 — SOU EXTENSION 3 GRANTED
- 02 Apr 2026 — SOU EXTENSION 3 FILED
- 02 Apr 2026 — SOU TEAS EXTENSION RECEIVED
- 05 Aug 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 04 Aug 2025 — SOU EXTENSION 2 GRANTED
- 04 Aug 2025 — SOU EXTENSION 2 FILED
- 04 Aug 2025 — SOU TEAS EXTENSION RECEIVED
- 01 Apr 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 31 Mar 2025 — SOU EXTENSION 1 GRANTED
- 31 Mar 2025 — SOU EXTENSION 1 FILED
- 31 Mar 2025 — SOU TEAS EXTENSION RECEIVED
- 08 Oct 2024 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 13 Aug 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 13 Aug 2024 — PUBLISHED FOR OPPOSITION